Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Diagnos Inc DGNOF


Primary Symbol: V.ADK

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Opinion & Analysis (TSXV:ADK)

    Diagnos increases footprint, and endorsements mount for AI tech that averts illness

    Fredrick William  June 4, 2020

    DIAGNOS poised for parabolic move as first of new cardio AI Applications comes to market

    James O'Rourke May 5, 2020

    DIAGNOS Inc. expands artificial intelligence platform, first mover in $386 billion/yr market

    Fredrick William  September 21, 2017

    DIAGNOS Inc. adoption curve to accelerate applying AI in healthcare

    Fredrick William  May 31, 2017

    DIAGNOS applying artificial intelligence in diabetes market, vertical growth trajectory in sight

    Fredrick William  December 2, 2016